The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients

Leptin reverses weight loss–induced changes in regional neural activity responses to visual food stimuli

Michael Rosenbaum, Melissa Sy, Katherine Pavlovich et al. · Journal of Clinical Investigation · 2008 · 406 citations · Full text

Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters

Kieran Davey, Siobhain M. O’Mahony, Harriët Schellekens et al. · Psychopharmacology · 2012 · 267 citations

Obesity, Psychoactive Drug, Microbiota Parameters +13

Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia

Rael D. Strous, Rachel Maayan, Raya Lapidus et al. · Archives of General Psychiatry · 2003 · 200 citations

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trial

Trino Baptista, Nairy Rangel, Virginia Fernández et al. · Schizophrenia Research · 2007 · 136 citations

Obesity, Metabolic Syndrome, Olanzapine Administration +9

Attenuation of Olanzapine-Induced Weight Gain With Reboxetine in Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study

Michael Poyurovsky, Ilanit Isaacs, Camil Fuchs et al. · American Journal of Psychiatry · 2003 · 134 citations